CRAIG ADAM R (President and CEO) sold 89.7% of their position (242.30K shares) of CTI BIOPHARMA CORP on the open market
Open‑market sale worth $1.45M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
common stock
Shares
+54K
Price / share
$0.84
Trade value
$45.42K
% of position
common stock
Shares
−46.10K
Price / share
$6.00
Trade value
$276.60K
% of position
common stock
Shares
−7.60K
Price / share
$6.01
Trade value
$45.65K
% of position
common stock
Shares
−300.00
Price / share
$6.01
Trade value
$1.80K
% of position
common stock
Shares
+188.30K
Price / share
$0.84
Trade value
$158.38K
% of position
common stock
Shares
−136.41K
Price / share
$6.00
Trade value
$818.45K
% of position
common stock
Shares
−200.00
Price / share
$6.00
Trade value
$1.20K
% of position
common stock
Shares
−26.70K
Price / share
$6.01
Trade value
$160.47K
% of position
common stock
Shares
−100.00
Price / share
$6.01
Trade value
$601.50
% of position
common stock
Shares
−16.40K
Price / share
$6.02
Trade value
$98.70K
% of position
common stock
Shares
−5.80K
Price / share
$6.03
Trade value
$34.97K
% of position
common stock
Shares
−2.70K
Price / share
$6.04
Trade value
$16.31K
% of position
Net shares
+0.00
Net value
-$1.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 11/9/2022 | M · Option Exercise | +54K | $0.84 | $45.42K | 193.8% | 27.86K | 81.86K |
| common stock Direct | 11/9/2022 | S · Sale | −46.10K | $6.00 | $276.60K | 56.3% | 81.86K | 35.76K |
| common stock Direct | 11/9/2022 | S · Sale | −7.60K | $6.01 | $45.65K | 21.2% | 35.76K | 28.16K |
| common stock Direct | 11/9/2022 | S · Sale | −300.00 | $6.01 | $1.80K | 1.1% | 28.16K | 27.86K |
| common stock Direct | 11/10/2022 | M · Option Exercise | +188.30K | $0.84 | $158.38K | 675.9% | 27.86K | 216.16K |
| common stock Direct | 11/10/2022 | S · Sale | −136.41K | $6.00 | $818.45K | 63.1% | 216.16K | 79.76K |
| common stock Direct | 11/10/2022 | S · Sale | −200.00 | $6.00 | $1.20K | 0.3% | 79.76K | 79.56K |
| common stock Direct | 11/10/2022 | S · Sale | −26.70K | $6.01 | $160.47K | 33.6% | 79.56K | 52.86K |
| common stock Direct | 11/10/2022 | S · Sale | −100.00 | $6.01 | $601.50 | 0.2% | 52.86K | 52.76K |
| common stock Direct | 11/10/2022 | S · Sale | −16.40K | $6.02 | $98.70K | 31.1% | 52.76K | 36.36K |
| common stock Direct | 11/10/2022 | S · Sale | −5.80K | $6.03 | $34.97K | 16.0% | 36.36K | 30.56K |
| common stock Direct | 11/10/2022 | S · Sale | −2.70K | $6.04 | $16.31K | 8.8% | 30.56K | 27.86K |
| Total | +0.00 | -$1.25M | ||||||
Non-Qualified Stock Option (right to buy)
Common Stock
54K shares
Shares
−54K
Strike price
0.8411
Held after
859.26K
Exercisable
—
Non-Qualified Stock Option (right to buy)
Common Stock
188.30K shares
Shares
−188.30K
Strike price
0.8411
Held after
670.95K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock54K shares | 11/9/2022 | M · Option Exercise | −54K | 0.8411 | — | 859.26K |
| Non-Qualified Stock Option (right to buy) Direct | Common Stock188.30K shares | 11/10/2022 | M · Option Exercise | −188.30K | 0.8411 | — | 670.95K |